Repeatability of ¹⁸F-FDG uptake measurements in tumors: a metaanalysis
Date
2012
Authors
de Langen, A.
Vincent, A.
Velasquez, L.
van Tinteren, H.
Boellaard, R.
Shankar, L.
Boers, M.
Smit, E.
Stroobants, S.
Weber, W.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Nuclear Medicine, 2012; 53(5):701-708
Statement of Responsibility
Adrianus J. de Langen, Andrew Vincent, Linda M. Velasquez, Harm van Tinteren, Ronald Boellaard, Lalitha K. Shankar, Maarten Boers, Egbert F. Smit, Sigrid Stroobants, Wolfgang A. Weber, and Otto S. Hoekstra
Conference Name
Abstract
PET with the glucose analog 18F-FDG is increasingly used to monitor tumor response to therapy. To use quantitative measurements of tumor 18F-FDG uptake for assessment of tumor response, the repeatability of this quantitative metabolic imaging method needs to be established. Therefore, we determined the repeatability of different standardized uptake value (SUV) measurements using the available data. Methods: A systematic literature search was performed to identify studies addressing 18F-FDG repeatability in malignant tumors. The level of agreement between test and retest values of 2 PET uptake measures, maximum SUV (SUVmax) and mean SUV (SUVmean), was assessed with the coefficient of repeatability using generalized linear mixed-effects models. In addition, the influence of tumor volume on repeatability was assessed. Principal component transformation was used to compare the reproducibility of the 2 different uptake measures. Results: Five cohorts were identified for this metaanalysis. For SUVmax and SUVmean, datasets of 86 and 102 patients, respectively, were available. Percentage repeatability is a function of the level of uptake. SUVmean had the best repeatability characteristics; for serial PET scans, a threshold of a combination of 20% as well as 1.2 SUVmean units was most appropriate. After adjusting for uptake rate, tumor volume had minimal influence on repeatability. Conclusion: SUVmean had better repeatability performance than SUVmax. Both measures showed poor repeatability for lesions with low 18F-FDG uptake. We recommend the evaluation of biologic effects in PET by reporting a combination of minimal relative and absolute changes to account for test–retest variability.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2012 by the Society of Nuclear Medicine, Inc.